Iron Replacement in Oesophagogastric Neoplasia

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2013
40 eligible patients with confirmed esophageal or gastric adenocarcinoma and anemia will be randomized to a control or intervention group for management of this anemia. The control group treatment will consist of standard treatments as governed by the clinical team (eg oral iron, blood transfusions) whilst the intervention group will be treated with intravenous iron III isomaltoside (Monofer ®). It is hypothesized that intravenous iron supplementation is more efficacious than standard therapies.
Epistemonikos ID: 51c3a4398d312f1f06ee3e51be2cacab774e1663
First added on: May 11, 2024